Business
FIRST MPS-VI PATIENT DOSED UNDER PHASE 2 TRIAL IN BRAZIL
FIRST MPS-VI PATIENT DOSED UNDER PHASE 2 TRIAL IN BRAZIL
About this update from Paradigm Biopharmaceuticals Ltd.
[{"type":"text","content":"Paradigm Biopharmaceuticals Ltd has released a press release. View Attachment","length":263,"tagName":"div"}]